School of Medicine, Queen's University, 15 Arch St., Kingston, ON, K7L 3L4, Canada.
Department of Obstetrics and Gynecology, Queen's University, 76 Stuart St., Victory 4, Kingston, ON, K7L 2V7, Canada.
Reprod Health. 2023 Jan 2;20(1):4. doi: 10.1186/s12978-022-01559-8.
The risk of premature ovarian insufficiency (POI) is increased in adolescent and young adult (AYA) cancer survivors, with the prevalence depending on cancer diagnosis, treatment, and patient factors. Prior studies are limited by sample size and type of cancer included. The objective of this study was to assess the risk of POI in female AYA survivors of non-gynecologic cancers, using a population-based approach.
This population-based retrospective cohort study comprises 21,666 females, 15-39 years old, diagnosed with a single non-gynecologic cancer in Ontario, Canada from 1995 to 2015. Through health administrative data linkage, participants were followed until their 40th birthday, December 31, 2018, bilateral oophorectomy, loss of health insurance eligibility or death. Each cancer survivor was matched to 5 females who were not diagnosed with cancer (unexposed, n = 108,330). Women with bilateral oophorectomy or a prior menopause diagnosis were excluded. POI was identified through use of the ICD-9 code for menopause (ICD9-627). Modified Poisson regression models were used to calculate the adjusted relative risk (aRR) of POI for AYA cancer survivors compared to unexposed individuals, adjusted for income, parity, age, and immigration status.
The occurrence of POI was higher in survivors of AYA cancer versus unexposed patients (5.4% vs. 2.2%). Survivors of AYA cancer had an increased risk of POI relative to unexposed patients (aRR 2.49; 95% CI 2.32-2.67). Risk varied by type of cancer: breast (4.32; 3.84-4.86), non-Hodgkin's lymphoma (3.77; 2.88-4.94), Hodgkin's lymphoma (2.37; 1.91-2.96), leukemia (14.64; 10.50-20.42), thyroid (1.26; 1.09-1.46) and melanoma (1.04; 0.82-1.32). Risk varied by age at time of cancer diagnosis, with a higher risk among females diagnosed at age 30-39 years (3.07; 2.80-3.35) than aged 15-29 years (1.75; 1.55-1.98).
AYA survivors of non-gynecologic cancers are at an increased risk of POI, particularly survivors of lymphomas, leukemia, breast, and thyroid cancer. The risk of POI is increased for those diagnosed with cancer at an older age. These results should inform reproductive counseling of female AYAs diagnosed with cancer.
青春期和年轻成年(AYA)癌症幸存者发生卵巢早衰(POI)的风险增加,其患病率取决于癌症诊断、治疗和患者因素。先前的研究受到样本量和所包括癌症类型的限制。本研究旨在通过基于人群的方法评估非妇科癌症的 AYA 女性幸存者发生 POI 的风险。
这项基于人群的回顾性队列研究包括 21666 名年龄在 15-39 岁的女性,她们于 1995 年至 2015 年在加拿大安大略省被诊断出患有单一非妇科癌症。通过健康行政数据链接,参与者被随访至 40 岁生日(2018 年 12 月 31 日)、双侧卵巢切除术、丧失健康保险资格或死亡。每位癌症幸存者都与 5 名未被诊断患有癌症的女性(未暴露,n=108330)相匹配。排除了双侧卵巢切除术或之前已绝经诊断的女性。通过 ICD-9 绝经代码(ICD9-627)来识别 POI。使用调整后的泊松回归模型来计算 AYA 癌症幸存者与未暴露个体相比 POI 的调整相对风险(aRR),并根据收入、产次、年龄和移民状况进行调整。
与未暴露患者相比,AYA 癌症幸存者发生 POI 的几率更高(5.4% vs. 2.2%)。与未暴露患者相比,AYA 癌症幸存者发生 POI 的风险更高(aRR 2.49;95%CI 2.32-2.67)。风险因癌症类型而异:乳腺癌(4.32;3.84-4.86)、非霍奇金淋巴瘤(3.77;2.88-4.94)、霍奇金淋巴瘤(2.37;1.91-2.96)、白血病(14.64;10.50-20.42)、甲状腺(1.26;1.09-1.46)和黑色素瘤(1.04;0.82-1.32)。风险因癌症诊断时的年龄而异,30-39 岁诊断的女性风险较高(3.07;2.80-3.35),而 15-29 岁诊断的女性风险较低(1.75;1.55-1.98)。
非妇科癌症的 AYA 幸存者发生 POI 的风险增加,特别是淋巴瘤、白血病、乳腺癌和甲状腺癌的幸存者。年龄较大时被诊断出癌症的患者发生 POI 的风险更高。这些结果应告知被诊断出癌症的 AYA 女性进行生殖咨询。